Moxibustion: Clinical Trials

8 trials of Moxibustion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 3 completed, 1 recruiting. 8 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Unknown 4, Completed 3, Recruiting 1
Phase 11Unknown 1

Follow Moxibustion: new trials by email Literature Review of Moxibustion trials Research Report on Moxibustion

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Moxibustion, Moxibustion Twice Daily Plus Best Available Treatment (BID Group), Best Available Treatment (BAT) - Steroid-Refractory Acute Graft-Versus-Host Disease, Acute Graft-Versus-Host Disease
Phase 2RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology422025-09-012026-05-07
High-tech Acupuncture for Treatment of Chronic Fatigue Syndrome
Acupuncture, moxibustion, placebo - Chronic Fatigue Syndrome
Phase 2UnknownHubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust2102016-11-012016-10-05
Sanfu Herbal Patch and Sanfu Moxibustion for Persistent Allergic Rhinitis: a Controlled Clinical Trial
Sanfu herbal patch, Sanfu moxibustion, Sanfu herbal patch and moxibustion - Patch,Chinese Herb, Moxibustion
Phase 2UnknownHubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust2002016-07-012018-03-26
Limiting Chemotherapy Side Effects by Using Moxa
Moxibustion - Breast Neoplasms, Colorectal Neoplasms
Phase 1 / Phase 2UnknownEast and North Hertfordshire NHS Trust252016-02-012016-05-24
The Activation on Prefrontal Cortex With Acupuncture and Moxibustion for Major Depressive Disorder: A Study of Functional Near Infrared Spectroscopy
acupuncture and moxibustion, Fluoxetine - Depressive Disorder, Major
Phase 2CompletedChengdu University of Traditional Chinese Medicine202014-01-012020-02-17
Acupuncture/Moxibustion for Irritable Bowel Syndrome (IBS)
Standard Acupuncture/Moxibustion (fixed protocol), Individualized Acupuncture/Moxibustion, Sham/Placebo Acupuncture/Moxibustion - Irritable Bowel Syndrome
Phase 2UnknownNew York University1712009-07-012016-09-22
Acupuncture/Moxibustion for Peripheral Neuropathy in HIV
Acupuncture/Moxibustion, Sham acupuncture/Placebo moxibustion - Peripheral Neuropathies, HIV Infections
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)502005-11-012019-09-11
Acupuncture and Moxa: A Randomized Clinical Trial for Chronic Diarrhea in HIV Patients
Acupuncture, Moxibustion - HIV Infections
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)1999-09-012008-03-07

Conditions studied

HIV Infections (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Anemia (1)  ·  Breast Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Depressive Disorder, Major (1)  ·  Diarrhea (1)  ·  Fatigue Syndrome, Chronic (1)  ·  Genital Neoplasms, Female (1)  ·  Graft vs Host Disease (1)  ·  Irritable Bowel Syndrome (1)  ·  Neoplasms (1)  ·  Neutropenia (1)  ·  Peripheral Nervous System Diseases (1)  ·  Rhinitis, Allergic (1)

Sponsors

Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust (2)  ·  National Center for Complementary and Integrative Health (NCCIH) (2)  ·  Chengdu University of Traditional Chinese Medicine (1)  ·  East and North Hertfordshire NHS Trust (1)  ·  New York University (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)

Countries

China (4)  ·  United States (3)  ·  United Kingdom (1)

Top investigators

Beverley A de Valois, PhD (1)  ·  Joyce K Anastasi, PhD, DrNP (1)  ·  Joyce K Anastasi, PhD, DrNP, FAAN, LAc (1)  ·  Joyce K. Anastasi, PhD,RN,LAc (1)  ·  Wu Junmei, Doctor (1)

Results publications

PMID 40315935

NIH funding

R01AT000146 (1), R01NR010730 (1)